Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: A randomised controlled trial

British Journal of Sports Medicine

Volumn 37, Issue 4, 2003, Pages 315-320

  Lebrun, C M ^a   Petit, M A ^a   McKenzie, D C ^a   Taunton, J E ^a   Prior, J C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE; TRIPHASIC CONTRACEPTIVE AGENT;

ADULT; AEROBIC CAPACITY; ARTICLE; ATHLETE; BIOASSAY; BODY HEIGHT; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; DYNAMOMETRY; ENDURANCE; ESTRADIOL BLOOD LEVEL; FATIGUE; FEMALE; FOLLICULAR PHASE; HEART RATE; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; LUNG GAS EXCHANGE; LUNG VENTILATION; LUTEAL PHASE; MEASUREMENT; MENSTRUAL CYCLE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NORMAL HUMAN; OVULATION; OXYGEN CONSUMPTION; PERFORMANCE; PHYSICAL ACTIVITY; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECORDING; SKINFOLD; TIME; TRAINING; VELOCITY;

ADOLESCENT; ADULT; ANTHROPOMETRY; BODY COMPOSITION; CONTRACEPTIVES, ORAL, HORMONAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KNEE JOINT; MENSTRUAL CYCLE; PHYSICAL ENDURANCE; SPORTS;

EID: 0043071262     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.37.4.315     Document Type: Article

References (26)

1. Collins DC. Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives. Am J Obstet Gynecol 1994;170:1508-13.
2. Coney P, Washenik K, Langley RG, et al. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomised, placebo-controlled trials. Contraception 2001;63:297-302.
3. Goodman AG, Goodman LS, Gilman A. The pharmacological basis of therapeutics. New York: MacMillian, 1980.
4. Giacomoni M, Falgairette G. Decreased submaximal oxygen uptake during short duration oral contraceptive use: a randomised cross-over trial in premenopausal women. Ergonomics 2000;43:1559-70.
5. Daggett A, Davies B, Boobis L. Physiological and biochemical responses to exercise following oral contraceptive use[abstract]. Med Sci Sports Exerc 1983;15:174.
6. Notelovitz M, Zauner C, McKenzie L, et al. The effect of low-dose contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol 1987;156:591-8.
7. Huisveld IA, Hospers JEH, Bernink MJ, et al. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women. Int J Sports Med 1983;4:97-103.
8. McNeill AW, Mozingo E. Changes in the metabolic cost of standardized work associated with the use of an oral contraceptive. J Sports Med 1981;21:238-44.
9. Lynch NJ, Nimmo MA. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Eur J Appl Physiol 1998;78:565-72.
10. Lebrun CM. Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med 1993;16:400-30.
11. Frankovich RJ, Lebrun CM. The athletic woman: menstrual cycle, contraception and performance. Clin Sports Med 2000;19:251-71.
12. Lebrun CM, McKenzie DC, Prior JC, et al. Effects of menstrual cycle phase on athletic performance. Med Sci Sports Exerc 1995;27:437-44.
13. Abraham GE, Maroulis GB, Marshall JB. Evaluation of ovulation and corpus luteum functioning using measurements of plasma progesterone. Obstet Gynecol. 1974;44:522-5.
14. Siri WE. Body composition from fluid spaces and density analysis of methods. In: Brozek J, Henschel A, eds. Techniques for measuring body composition. Washington, DC: National Academy of Science and National Research Council, 1961.
15. Parkhouse WS, McKenzie DC, Hochachka PW, et al. Buffering capacity of deproteinized human vastus lateralis muscle. J Appl Physiol 1985;58:14-17.
16. MacDougall JD, Wenger HA, Green HA, eds. Physiological testing of the high-performance athlete. 2nd ed. Champaign, IL: Human Kinetics Publishers, 1991.
17. Cunningham DA, Faulkner JA. The effect of training on aerobic and anaerobic metabolism during a short exhaustive run. Med Sci Sports Exerc 1969;1:65-9.
18. Bryner R, Toffle R, Ullrich I, et al. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med 1996;30:36-40.
19. Bonekat H, Dombovy M, Staats B. Progesterone-induced changes in exercise performance and ventilatory responses. Med Sci Sports Exerc 1987;19:118-23.
20. Beck P. Contraceptive steroids: modification of carbohydrate and lipid metabolism. Metabolism 1973;22:841-55.
21. Bonen A, Haynes FW, Graham TE. Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol 1991;70:1917-27.
22. Ashley CD, Kramer ML, Bishop P. Estrogen and substrate metabolism: a review of contradictory research. Sports Med 2000;29:221-7.
23. Petrofsky JS, LeDonne DM, Rinehart JS, et al. Isometric strength and endurance during the menstrual cycle. Eur J Appl Phsyiol 1976;35:1-10.
24. Fortney SM, Beckett WS, Carpenter AJ, et al. Changes in plasma volume during bed rest: effects of the menstrual cycle and estrogen administration. J Appl Physiol 1988;65:525-33.
25. Greenblatt RB. Oral contraceptives: the state of the art. Clin Ther 1985;8:6-27.
26. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Contraception 1998;58:345-9.